Clinical Trials
2 trialsNCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT00280007 2010-04-22
Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma
Medical University of Vienna
Phase 2 Terminated